Prevalence Of Pulmonary Hypertension In Systemic Sclerosis [avaliação Da Prevalência De Hipertensão Pulmonar Na Esclerose Sistêmica]

dc.creatorde Azevedo A.B.C.
dc.creatorSampaio-Barros P.D.
dc.creatorTorres R.M.
dc.creatorMoreira C.
dc.date2004
dc.date2015-06-26T14:24:02Z
dc.date2015-11-26T14:12:54Z
dc.date2015-06-26T14:24:02Z
dc.date2015-11-26T14:12:54Z
dc.date.accessioned2018-03-28T21:13:35Z
dc.date.available2018-03-28T21:13:35Z
dc.identifier
dc.identifierRevista Brasileira De Reumatologia. , v. 44, n. 1, p. 31 - 39, 2004.
dc.identifier4825004
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-55449120724&partnerID=40&md5=1ba2e8fce3c9f072ecf9eb0f6c4700af
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/94330
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/94330
dc.identifier2-s2.0-55449120724
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1242134
dc.descriptionObjective: To assess the prevalence of pulmonary arterial hypertension (PAH) in patients with diagnosis of systemic sclerosis (SSc) evaluated at a university tertiary service. Methods: Fifty-seven SSc patients attending the Rheumatology outpatient clinic of HC-UFMG were studied by clinical assessment addressed to cardiopulmonary system, pulmonary function tests and Doppler echocardiography (ECO). The following criteria were considered for the diagnosis of PAH: pulmonary arterial systolic pressure (PASP) ≥ 40mmHg and/or the presence of direct or indirect signs of PAH found during the ECO. Results: Sixteen patients (28%) were found to have the diagnosis of PAH at ECO, 13 with PASP ≥ 40mmHg and 3 with direct and indirect signs of PAH; 8 patients had isolated PAH and 8, PAH secondary to pulmonary fibrosis. Nine patients had suggestive signs of cor pulmonale at ECO; 6 of these patients presented PASP ≥ 40mmHg and 3 PASP between 35 and 40mmHg; 1 of them was not symptomatic and 8 had clinical exam suggestive of PAH. Regarding the clinical and laboratory variables studied, it was observed statistical association between PAH and elevated erythrocyte sedimentation rate (ESR) (p = 0,004). Conclusions: There was a prevalence of PAH in SSc similar to that observed in the literature, in spite of limitations in this comparison. The assessment of PAH by ECO is accessible and practical; however, it is necessary to review the cut off of the PASP levels considered for the diagnosis of PAH in SSc, especially when considering an early diagnosis.
dc.description44
dc.description1
dc.description31
dc.description39
dc.descriptionMarques Neto, J.F., Sampaio-Barros, P.D., Esclerose Sistêmica (2001) Reumatologia Diagnóstico e Tratamento, pp. 465-488. , Em Moreira C, Carvalho MAP (Editores): 2a edição, MEDSI, Belo Horizonte
dc.descriptionWigley, F.M., Clinical Features of Systemic Sclerosis (1998) Rheumatology, 7 (9), pp. 1-14. , Em Klippel JH, Dieppe PA (Editores): 2a edição, Mosby, London
dc.descriptionDenton, C.P., Black, C.M., Pulmonary Vascular Involvement in Systemic Sclerosis (2004) Systemic sclerosis, pp. 184-194. , Em Clements PJ, Furst DE (Editores): 2a edição, Lippincott Williams &amp
dc.descriptionWilkins, Filadélfia
dc.descriptionDenton, C.P., Black, C.M., Pulmonary hypertension in systemic sclerosis (2003) Rheum Dis Clin North Am, 29, pp. 371-390
dc.descriptionDenton, C.P., Cailes, J.B., Phillipis, G.D., Wells, A.U., Black, C.M., du Bois, R.M., Comparison of Doppler echocardiography and right heart catheterization in systemic sclerosis (1997) Br J Rheumatol, 36, pp. 239-243
dc.descriptionPreliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Arthritis Rheum, 23, pp. 581-590. , Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee
dc.descriptionLeroy, E.C., Black, C., Fleischmajer, R., Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis (1988) J Rheumatol, 15, pp. 202-205
dc.descriptionOtto, C.M., (2000) Textbook of Clinical Echocardiography, , 2aedição, W. B. Saunders, Filadélfia
dc.description(1996) J Bras Pneumol, 22, pp. 105-164. , I Consenso Brasileiro sobre Espirometria 1996
dc.descriptionSteen, V., Predictors of end stage lung disease in systemic sclerosis (2003) Ann Rheum Dis, 62, pp. 97-99
dc.descriptionMagliano, M., Isenberg, D.A., Hillson, J., Pulmonary hypertension in autoimmune rheumatic diseases. Where are we now? (2002) Arthritis Rheum, 46, pp. 1997-2009
dc.descriptionVancheeswaran, R., Magoulas, T., Efrat, G., Circulating endothelin-1 levels in systemic sclerosis subsets - a marker of fibrosis or vascular dysfunction? (1994) J Rheumatol, 21, pp. 1838-1844
dc.descriptionMitri, G.M., Lucas, M., Fertig, N., Steen, V.D., Medsger Jr., T.A., A comparison between anti-Th/To and anticentromere antibodypositive systemic sclerosis patients with limited cutaneous involvement (2003) Arthritis Rheum, 48, pp. 203-209
dc.descriptionSacks, D.G., Okano, Y., Steen, V.D., Curtiss, E., Shapiro, L.S., Medsger Jr., T.A., Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: Association with serum anti-U3RNP antibody (1996) J Rheumatol, 23, pp. 639-642
dc.descriptionSteen, V., Mesdger Jr., T.A., Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement (2003) Arthritis Rheum, 48, pp. 516-522
dc.descriptionYamane, K., Ihn, H., Asano, Y., Clinical and laboratory features of scleroderma patients with pulmonary hypertension (2000) Rheumatology, 39, pp. 1269-1271
dc.descriptionSteen, V., Conte, C., Owens, G., Mesdger Jr., T.A., Severe restrictive lung disease in systemic sclerosis (1994) Arthritis Rheum, 37, pp. 1283-1289
dc.descriptionMorgan, C., Knight, C., Lunt, M., Black, C.M., Silman, A.J., Predictors of end stage lung disease in a cohort of patients with scleroderma (2003) Ann Rheum Dis, 62, pp. 146-150
dc.descriptionSackner, M.A., Heinz, E.R., Steinberg, A.J., The heart in scleroderma (1966) Am J Cardiol, 17, pp. 542-559
dc.descriptionStupi, A.M., Steen, V., Owens, G.R., Barnes, E.L., Rodnan, G.P., Mesdger Jr., T.A., Pulmonary hypertension in the CREST Syndrome variant of systemic sclerosis (1986) Arthritis Rheum, 29, pp. 515-524
dc.descriptionSampaio-Barros, P.D., Leme, C.A., Marques Neto, J.F., Valor do ecocardiograma com doppler na esclerose sistêmica (1995) Rev Bras Reumatol, 35, pp. 327-331
dc.descriptionKoh, E.T., Lee, P., Gladman, D.D., Abu-Shakra, M., Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients (1996) Br J Rheumatol, 35, pp. 989-993
dc.descriptionBattle, R.W., Davitt, M.A., Cooper, S.M., Prevalence of pulmonary hypertension in limited and diffuse scleroderma (1996) Chest, 110, pp. 1515-1519
dc.descriptionMurata, I., Takenaka, K., Yoshinoya, S., Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. a Doppler echocardiographic study of 135 Japanese patients (1997) Chest, 111, pp. 36-43
dc.descriptionMacGregor, A.J., Canavan, R., Knight, C., Pulmonary hypertension in systemic sclerosis: Risk factors for progression and consequences for survival (2001) Rheumatology, 40, pp. 453-459
dc.descriptionMukerjee, D., St George, D., Coleiro, B., Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach (2003) Ann Rheum Dis, 62, pp. 1088-1093
dc.descriptionRich, S., (1998) World Symposium on Primary Pulmonary Hypertension, , www.who.int/ncd/cvd/pph.html, Evian, France
dc.descriptionMerkel, P.A., Clements, P.J., Reveille, J.D., Suarez-Almazor, M.E., Valentini, G., Furst, D.E., Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6 (2003) J Rheumatol, 30, pp. 1630-1647
dc.languagept
dc.publisher
dc.relationRevista Brasileira de Reumatologia
dc.rightsfechado
dc.sourceScopus
dc.titlePrevalence Of Pulmonary Hypertension In Systemic Sclerosis [avaliação Da Prevalência De Hipertensão Pulmonar Na Esclerose Sistêmica]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución